Public health researchers in Sweden hid data showing that the Pandemrix swine flu vaccine associated with narcolepsy is also linked to a significant increase in type 1 diabetes in children, newly published data reveals.
Forced to release public documents, the Medical Products Agency of Sweden has now, three years after publishing findings based on distorted data, confirmed that they removed 141 cases of Type 1 diabetes from the pool of data before they analysed it. The omitted data appears in a “follow-up” to the old study in the current issue of the Journal of Internal Medicine, but the agency has been accused of scientific misconduct.
A letter published in the same journal says the deletion violated protocol. “The protocol violation made a great difference to the study outcome, a statistically significant increased risk turned into no statistically significant association,” Lars Andersson at the Karolinska Institutet in Solna, Sweden wrote.
Excluded from the data were 52 cases of juvenile diabetes from the 10–19-year-old age group. Taking into account these cases (14 unvaccinated/38 vaccinated), the MPA now reports 26% more Type 1 diabetes cases in vaccinated than in unvaccinated persons, a value which is statistically significant.
Pandemrix, one of two swine flu vaccines in circulation in Europe during the so-called “pandemic” flu year of 2009, was previously found responsible for a 12-fold spike in childhood cases of the immune-mediated sleep disorder, narcolepsy.
The Swedish state has offered some financial compensation to children who developed lifelong narcolepsy as a result of vaccination with Pandemrix, although manufacturer GlaxoSmithKline has blanket protection from lawsuits because of the drug’s vaccine status.
The MPA held a press conference in 2013, however, to reassure the Swedish public that there was no link between the vaccine and other immune disorders.
In 2014, researchers at the health watchdog agency, led by Senior Expert Ingemar Persson, published the flawed study based on the limited data pool. They concluded, “…we found no convincing evidence of a risk increase for selected neurological or immune-related diseases, except narcolepsy, in Pandemrix-vaccinated compared with unvaccinated individuals”.
The new follow-up acknowledges that the data was “erroneously left out” of the first analysis. Now, according to Andersson’s letter, children who were diagnosed with diabetes following the vaccine are invited to come forward. According to the Journal of Internal Medicine, “Young persons (10–19 years) in whom type 1 diabetes was diagnosed up to 2 years after receiving the Pandemrix vaccine should now be able to get indemnity from the state by referring to this Letter to the Editor containing new authority data, previously unknown to the public.”
‘Independent’ review, no retraction
Andersson first noted the discrepancies in the MPA data in 2013 in a letter to the journal and again in 2014. The MPA stood by its study, saying there was no “true causal risk relationship”.
In their response letter accompanying their admission to the newly reported risk association, they say they have been exonerated by an independent expert review and they conclude, “anyone, including LA, who draws definite conclusions regarding causality without taking the complexity of these issues into account, but rather claims manipulation of results and refers to ‘hidden authority data’, should consider his responsibility for counteracting a constructive discussion on the important issue of vaccine”.
Ulf de Faire, Editor-in-Chief of the Journal of Internal Medicine said an “independent, external very experienced scientist” named Stig Wall from Umeå University, Sweden had conducted the review and the Karolinska Institutet dismissed allegations of misconduct.
Wall is a former director of the WHO Collaborating Centre on Epidemiological Surveillance and Public Health Training, and according to his bio was a consultant to the Swedish International Development Agency’s research department, SAREC which oversees vaccine development. Wall was involved in several projects in the developing world including Nicaragua and Tanzania, where Sweden tested a new HIV vaccine.
“We have been fully open on this case and have published not only the original article but also all letters to the editor that followed including subsequent responses from the authors,” said de Faire. “We cannot see that there are any reasons to retract the original article”.
New cases yet to emerge
Pulling the cases from the data pool hid the diabetes connection, however, and many Swedish parents are unaware of the link to the vaccine. “The removal of cases caused the study to shrink and so did its power to detect significant associations,” according to Andersson’s letter. He added that many more cases still have not been reported in the Swedish registry, so the actual numbers of children who will have the lifelong, pharmaceutically-dependent autoimmune disease which attacks the pancreas may be much higher.
In 2011, Sweden recorded the second highest rate of Type 1 diabetes in the world (at 43.1 cases per 100,000 people), next to Finland (57.6 per 100,000). Both countries distributed the Pandemrix vaccine as part of a mass global public health campaign against the flu pandemic that failed to materialize.
The incidence of childhood diabetes is increasing worldwide. It is one of more than 88 previously rare autoimmune diseases that are growing at an alarming rate among children, without explanation from public health.
The Pandemrix link to diabetes refutes public health claims that there is no link between vaccinations and autoimmune disease, a subject which has gained increasing attention in immunology literature in recent years.
‘Oh my God, I can’t believe we did what we did’
The revelation that public officials in Sweden have obscured data about vaccine dangers is the latest in a spate of violations of public trust by health agencies globally.
This month, environmental lawyer Robert F. Kennedy Jr. announced that then President-elect Donald Trump asked him to head a commission on vaccine safety and scientific integrity.
On the agenda at such a probe will undoubtedly be accusations that top scientists at the US Centers for Disease Control obscured data showing that researchers at the agency knew, at least as far back as 2001, about a connection between the triple MMR (measles, mumps, rubella) vaccine and autism.
CDC top scientist William Thompson contacted Brian Hooker, a bioengineer professor at Simpson University and the father of an autistic child. Over a series of about 40 phonecalls in 2013 and 2014, he leaked him hundreds of pages of data showing that he and other agency researchers had colluded to obscure and then shred data demonstrating a link between the MMR and the neurological disorder now epidemic in children.
“Oh my God, I can’t believe we did what we did,” Thompson confessed to Hooker in on tape. The telephone tapes, and Thompson’s copies of the shredded data are the basis of the 2016 documentary film, Vaxxed: From Cover-Up to Catastrophe.
Other evidence of widespread CDC corruption includes a 2009 Department of Health and Human Services report which found that 97 percent of committee members sitting on vaccine advisory panels had undisclosed ties to the $30 billion vaccine industry.
The fact that the CDC itself owns 56 vaccine patents suggest an enormous conflict of interest within the agency which buys and sells more than $4 billion in vaccine stock every year.